Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).
This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice.
With its innovative design and optimized separation technology, Exprecell enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.
What makes Exprecell special?
- MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).
- Flexibility: Compatibility with Luer-Lock syringes allows flexible system integration and secure fluid transfer in a syringe of choice.
- Safety: A closed system design limits exposure to external contaminants.
- Usability, design, handling: Designed for a soft-single-spin process, enabling autologous PRP |Fluid-PRF preparation from whole blood with 5-minute spin time at 420xg.
Available Now
Exprecell is now available for healthcare professionals in the EU, UK & Switzerland. With this launch, Croma-Pharma further extends its commitment to providing a comprehensive and innovative portfolio to healthcare professionals.
